The pathophysiology of restenosis following percutaneous transluminal coronary angioplasty;Patofysiologien ved restenose efter perkutan transluminal koronar angioplastik

Ugeskrift for Laeger

Volumn 160, Issue 9, 1998, Pages 1302-1306

  Holm, Anne Mette ^a   Haunsø, Stig ^a   Hansen, Peter Riis ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; HUMAN; PATHOPHYSIOLOGY; RECURRENT DISEASE; REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; HUMANS; RECURRENCE;

EID: 0032559496     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Dangas G, Fuster V. Management of restenosis after coronary intervention. Am Heart J 1996; 132: 428-36.
2. Thayssen P. Perkutan transluminal koronar angioplastik ved iskæmisk hjertesygdom. Ugeskr Læger 1994; 156: 4445-9
3. Schwartz SM, deBlois D, O'Brien ERM. The intima. Soil for atherosclerosis and restenosis. Cire Res 1995: 77: 445-65.
4. Bauters C, Meurice T, Hamon M, McFadden E, Lablanche J, Bertrand ME. Mechanisms and prevention of restenosis: from experimental models to clinical practice Cardiovasc Res 1996, 31. 835-46.
5. Kuntz RE, Baim DS. Defining coronary restenosis. Newer clinical and angiographic paradigms. Circulation 1993, 88: 1310-23.
6. Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
7. Lefkovits J, Ivanhoe RJ, Califf RM, Bergelson BA, Anderson KM, Stoner GL et al. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (abciximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996; 77: 1045-51.
8. Ubby P, Warner SJC, Salomon RN, Birinyi LK. Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med 1988; 318: 1493-8.
9. Nikol S, Isner JM, Pickering G, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest 1992; 90: 1582-92
10. Muller DWM, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis. J Am Coll Cardiol 1992, 19 418-32.
11. Pratt RE, Dzau VJ Pharmacological strategies to prevent restenosis. Lessons learned from blockade of the renin-angiotensin system. Circulation 1996; 93: 848-52.
12. Andersen HR, Mæng M, Thorwest M, Falk E Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury. Insights from a porcine coronary (re) stenosis model. Circulation 1996, 93: 1716-24.
13. Mintz GS, Popma JJ, Pichard AD, Kent KM, Satler LF, Wong SC et al. Arterial remodeling after coronary angioplasry. A serial intravascular ultrasound study. Circulation 1996; 94: 35-43.
14. Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circu-lation 1996; 94: 1247-54.
15. Förstemann U, Nakane M, Tracey WR, Pollock JS. Isoforms of nitric oxide synthase: functions in the cardiovascular system. Eur Heart J 1993; 14 (suppl 1): 10-15.
16. Shimokawa H, Flavahan NA, Vanhoutte PM. Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein. Circ Res 1989; 65: 740-53.
17. Meurice T, Bauters C, Auffray J, Vallet B, Hamon M, Valero F et al. Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. Circulation 1996; 93: 18-22.
18. Strauss BH, Robinson R, Batchelor WB, Chrisholm RJ, Ravi G, Natarajan MK et al. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res 1996; 79: 541-50.
19. Geng Y, Wu Q, Muszynski M, Hansson GK, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α. and interleukin-1β. Arterioscler Thromb Vasc Biol 1996; 16: 19-27.
20. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995; 147: 267-77.
21. Miano JM, Vlasic N, Tota RR, Stemerman MB. Localization of fos and jun proteins in rat aortic smooth muscle cells after vascular injury. Am J Pathol 1993; 142: 715-24.
22. Pardee AB. G1 events and regulation of cell proliferation. Science 1989; 246: 603-8.
23. Yan Z, Yokota T, Zhang W, Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res 1996; 79: 38-44.
24. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4.
25. Hamon M, Vallet B, Bauters C, Wernert N, McFadden EP, Lablanche J et al. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation 1994; 90: 1357-62.
26. The ACCORD Study Investigators. Nitric oxide donors reduce restenosis after coronary angioplasty: the ACCORD Study [abstract]. J Am Coll Cardiol 1994; 23 (suppl): 59A.
27. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990; 111: 2149-58.
28. Ferns GAA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointirnal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991, 253: 1129-32.
29. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimai thickening in a rat model of balloon angioplasty. J Clin Invest 1992; 89: 507-11.
30. Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M et al. Trapidil (triazolopyrimidine). a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Results of the randomized, double-blind STARC study. Circulation 1994; 90: 2710-5.
31. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-13.
32. Olson NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor. Am J Pathol 1992; 140: 1017-23.
33. Powell JS, Clozel J, Muller RKM, Kuhn H, Hefti F, Hosang M et al. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-8.
34. The Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR Study: a multicenter, randomized, double-blind placebocontrolled trial. Circulation 1992; 86: 100-10.
35. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimai hyperplasia in a rat model. J Clin Invest 1994; 93: 1172-8.
36. Edelman ER, Karnovsky MJ. Contrasting effects of the intermittent and continuous administration of heparin in experimental restenosis. Circulation 1994; 89: 770-6.
37. Ellis SG, Roubin GS, Wilentz J, Douglas JS, King III SB. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989; 117: 777-82.
38. Eeckhout E, Kappenberger L, Goy J. Stents for intracoronary placement current status and future directions. J Am Coll Cardiol 1996; 27. 757-65.
39. Feldman IJ, Tahlil O, Steg G. Perspectives of arterial gene therapy for the prevention of restenosis. Cardiovasc Res 1996; 32: 194-207.
40. Bennett MR, Schwartz SM. Antisense therapy for angioplasty restenosis. Some critical considerations. Circulation 1995; 92: 1981-93.